Drug interactions
Cyclophosphamide + Doxorubicin liposomal
Severity: Moderate
Cyclophosphamide and Doxorubicin liposomal: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both agents are used together in chemotherapy regimens, and the combination increases overall toxicity, including myelosuppression and cardiotoxicity. Cyclophosphamide can potentiate anthracycline cardiac injury, while hemorrhagic cystitis is a cyclophosphamide effect that may be reported with combination regimens.
What this interaction means in plain words
Cyclophosphamide and Doxorubicin liposomal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Additive pharmacodynamic toxicity, with cyclophosphamide possibly enhancing anthracycline cardiotoxicity; no specific pharmacokinetic mechanism is established.
What to do
Monitor blood counts and cardiac function (such as ejection fraction) regularly, and maintain hydration with uroprotection (mesna) for high-dose cyclophosphamide. Track cumulative anthracycline dose.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cyclophosphamide and Doxorubicin liposomal, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Cyclophosphamide
Frequently asked questions
Can I take Cyclophosphamide with Doxorubicin liposomal?
MediHelp rates the interaction as moderate. Cyclophosphamide and Doxorubicin liposomal can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both agents are used together in chemotherapy regimens, and the combination increases overall toxicity, including myelosuppression and cardiotoxicity. Cyclophosphamide can potentiate anthracycline cardiac injury, while hemorrhagic cystitis is a cyclophosphamide effect that may be reported with combination regimens.
How serious is the interaction between Cyclophosphamide and Doxorubicin liposomal?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and cardiac function (such as ejection fraction) regularly, and maintain hydration with uroprotection (mesna) for high-dose cyclophosphamide. Track cumulative anthracycline dose.
What other medicines interact with Cyclophosphamide?
MediHelp also lists interactions of Cyclophosphamide with, for example, Adenovirus types 4 and 7 live, Belatacept, Bendamustine. The full list is on the Cyclophosphamide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
